FDA
Across the US: Hemp & CBD News Briefs
Issues surrounding the regulation of hemp and CBD on the state and federal levels have been dominating news headlines in January. Here, a glimpse...
The Shutdown: Effects on Industry
Washington, D.C.--This is the longest shutdown in U.S. history, today being its 25th day. As it goes on, furloughed employees are being deemed “essential,”...
NPA Submits Comments to FDA Requesting Transparency
Washington, D.C.—The Natural Products Association (NPA) said in a press release that it submitted comments to the FDA regarding a new proposal to share...
Recall: Rhino Male Enhancement Pills
Boynton Beach, FL--In response to FDA analysis, Happy Together, Inc., has issued a voluntary recall of its Rhino 5k capsules. The product, which is distributed...
Oskri Organics Recalls Products
Lake Mills, WI—Oskri Organics Corp. is recalling several products due to a possible health risk, according to an announcement from the company.
The products at issue...
NPA Questions FDA’s Lack of Guidance for Dietary Supplements
Washington, D.C.—In comments made to the FDA, the Natural Products Association (NPA) questioned why the Agency's draft guidance for food labeling serving sizes does not...
NPA Submits Comments to FDA Regarding GMPs for Cosmetic Products
Washington, D.C.—The Natural Products Association (NPA) submitted comments to the FDA outlining a framework for developing Good Manufacturing Practices (GMPs) for cosmetic products, according...
Trump Signs Farm Bill; FDA Speaks on the Legality of CBD
Washington, D.C.—The signing of the Farm Bill by President Trump drew reactions from the industry which were, overall, positive. Yet moments after the bill...
E. Coli Traced to One Farm; 7 More People Fall Ill
Washington, D.C.—As of yesterday, the CDC announced that another 7 ill people have been included in the E. coli investigation, while the FDA announced...
CRN Responds to Creation of Dietary Supplement Working Group
Washington, D.C.—The Council for Responsible Nutrition (CRN) has responded to the statement made by Scott Gottlieb, M.D., commissioner of the FDA, regarding the new...
